Welcome to #WeAreGreenKey, where we shine a spotlight on our powerhouse recruiting team. 

We met up with Dustin Bernardi, Technical Recruiter on the Marketing Technology team at Green Key. He elaborated on the hottest roles in the market right now, as well as the challenges he expects his clients to face due to the economy in the next year.  

What are some hiring trends you’re seeing in MarTech right now? 

It started slowing down at the end of 2022. But a lot of smaller companies and agencies are hiring. It’s becoming more important for companies to focus on marketing technology and automation. They have a lot of opportunities in these fields to invest in. This next year it’s going to grow even more. In terms of the demand for certain roles, I’ve been seeing a lot of clients hiring product marketing managers, which is great because several candidates will come through with both product and marketing experience. 

Are there any challenges you see MarTech clients facing this year? 

It can be challenging for clients to keep good talent. With so many jobs being remote, candidates in our field have more jobs to choose from, so it can be hard to keep people in one spot. The way the economy is going, some companies might have to dial back on how much they’re spending on employees, while other companies can spend more. Recruitment agencies are helping a lot right now. Companies can’t always just put out a job description and find good candidates; agencies can help be that bridge. 

What steps would you suggest to a candidate looking to break into the industry? 

I definitely think it helps to work with an agency and build relationships. We, as recruiters, are interested in the wellbeing of the candidate, especially here at Green Key. We know the market really well and what companies need. This will allow candidates to hone in on certain skills and be aware of what the next biggest trend in the industry is. Even if you don’t find a job though an agency, being able to create that relationship can lead to future opportunities and connections. 

In terms of education, the experience I see is so much more spread out than you expect. It’s not just Marketing. I’ve seen candidates with Sociology and Psychology degrees. It’s a field where you can really learn and grow from the ground up. 

What are your professional goals in the MarTech recruiting space for 2023? 

By the end of the year, I want to start working on the business development side of things and creating a pipeline of clients. I see our team really thriving and expanding in 2023.  

What was your professional experience prior to recruiting for MarTech? 

I started my career in technical recruiting, where I recruited software developers and software engineers at a couple different companies. I held a non-recruiting job after that, but really wanted to get back into agency work because I felt like that was where I belonged. I came to Green Key in July 2022. 

author avatar
Green Key
Jun 6, 2023

Blood Banks Seeking Healthy and Recovered Volunteers

A Red Cross plea last month for blood donors averted what the agency described as a shortage so severe some hospitals were only days from running out of blood.

So many volunteers stepped forward that the Red Cross now deems the supply “adequate.” “We say that cautiously, because we don’t know what will come,” Paul Sullivan, senior vice president of the American Red Cross told the Washington Post.

Now, besides continuing to urge healthy people to give blood, hospitals and blood banks are asking those who have recovered from COVID-19 to donate plasma.

In the tri-state area, the New York Blood Center and Mount Sinai Hospital have issued calls for recovered COVID-19 persons to donate.

“If you had #COVID19 and have recovered you can help save a life. Your blood may contain antibodies that fight the virus and can help critically ill people. Please fill out this form to see if you are eligible to be a volunteer: https://bit.ly/2vTHALk,” the hospital Tweeted.

Friday, the Food and Drug Administration approved plans to test two potential therapies derived from human blood. “These are called convalescent plasma and hyperimmune globulin and are antibody-rich blood products made from blood donated by people who have recovered from the virus,” the FDA said.

The FDA program supplements the National COVID-19 Convalescent Plasma Project, an ad hoc effort organized by physicians and scientists across the country to investigate using convalescent plasma against the coronavirus. The project developed guidelines for using plasma and has detailed information for potential donors and Covid-19 patients.

Before the FDA acted, some of the researchers in the project were independently testing the antibody-rich plasma on a handful of seriously sick patients. It’s too soon to know the outcome, but initial reports suggest the therapy may be lessening their symptoms.

Using blood and plasma from recovered patients goes back more than 100 years. Before antibiotics, it was one of the only therapies available. It was sufficiently successful that it’s been used to treat other types of diseases such as SARS and Ebola. Though clinical studies of the therapies are few, a detailed analysis published in 2014 in The Journal of Infectious Diseases concluded, “Convalescent plasma may reduce mortality and appears safe.”

Meanwhile, blood banks across the country are looking to healthy, uninfected individuals to make up for the cancellation of blood drives, which provide about 80% of the nation’s blood supply. There’s still a need for blood, even though demand has lessened as elective surgeries are postponed and accidents and traumatic injuries have declines with fewer people driving.

At Ohio’s Cleveland Clinic, which conducted its own blood drive, emergency physician Baruch Fertel said that as long as donations continue, “We can stay out of trouble. But we’re not out of the woods. Folks who are healthy and recovered should consider giving blood.”

Photo by Testalize.me on Unsplash


author avatar
Green Key